Laura Lee Sandler, Chief Operating Officer of Oruka Therapeutics, Inc. (), sold a total of 5,000 shares of the company’s common stock for approximately $459,101 on September 1, 2026. The transactions were executed as part of a Rule 10b5
September 9, 2026
Trending
